This is a fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract, valued at $10,122.32, is for the delivery of DUOPA, a medication used to treat Parkinson's disease. The contract has an ultimate completion date of June 20, 2025 and was awarded on March 21, 2025. Accredo Health Group, Inc. is a key distributor of complex and high-value medications, primarily serving the healthcare needs of veterans through the VA's Veterans Integrated Service Networks (VISNs). This contract is part of Accredo's broader federal contract history with the VA, which includes the delivery of various specialty pharmaceuticals to treat conditions such as pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic conditions.
Generated 3/26/25, 9:54 AM